Volume : 09, Issue : 11, November – 2022

Title:

09.PREVALENCE OF DYSLIPIDEMIA IN HYPERTENSIVE AND DIABETIC PATIENTS IN A TERTIARY HOSPITAL IN PAKISTAN

Authors :

Zulquernain Ahmed Zoak, Tayyaba Naeem, Ishfaq Ahmad, Dr. Muhammad Arsal, Ali Hassan Rizvi, Dr. Afaq Ahmad

Abstract :

Background: Hypertension and diabetes play a significant role in developing cardiovascular disorders. Meanwhile, dyslipidemia also plays a central role in the progression of atherosclerotic disease. The study aims to assess the association of dyslipidemia in diabetic and hypertensive patients, as this population is at a higher risk of ischaemic heart diseases.
Materials and Methods: A cross-sectional study was conducted at the Pathology department of a tertiary care hospital in Pakistan. Using the WHO calculator, a sample size of 130 (CI 8.6) was calculated. All the participants were above 18 years of age. The patients with a previous history of myocardial infarction, stroke, or type 1 diabetes, with fasting blood sugar of less than 126mg/dl and who did not give consent were excluded from the study. Fasting lipid profiles of all the participants were carried out. The study outcome was measured in terms of percentages of diabetic and hypertensive patients having dyslipidemia.
Results: The mean age of the patients was 54.8 + 7.6 years. Of 130 cases, 52.3% of participants had diabetes, whereas 47.7% had hypertension. Dyslipidemia was found in 73.1% of diabetic and 66.12% of hypertensive patients, and this association was significant (p-value <0.001)
Conclusion: Dyslipidemia is directly associated with diabetes and hypertension. Thus strict monitoring of diabetic and hypertensive patients with dyslipidemia should be done to avoid developing cardiovascular disorders.
Keywords: Dyslipidemia, diabetes, hypertensive patients’ prevalence, Pakistan

Cite This Article:

Please cite this article in press Zulquernain Ahmed Zoak et al, Prevalence Of Dyslipidemia In Hypertensive And Diabetic Patients In A Tertiary Hospital In Pakistan.,Indo Am. J. P. Sci, 2022; 09(11).

Number of Downloads : 10

References:

1. Otsuka T, Takada H, Nishiyama Y, Kodani E, Saiki Y, Kato K et al. Dyslipidemia and the Risk of Developing Hypertension in a Working‐Age Male Population. J Am Heart Assoc 2016; 5:3.
2. Boo S, Yoon YJ, Oh H. Evaluating the prevalence, awareness, and control of hypertension, diabetes, and dyslipidemia in Korea using the NHIS-NSC database. A cross-sectional analysis. Medicine (Baltimore) 2018; 97:51
3. Dalal JJ, Padmanabhan TNC, Jain P, Patil S, Vasnawala H, Gulati A. LIPITENSION: Interplay between dyslipidemia and hypertension. Indian J Endocrinol Metab. 2012; 16: 240-245
4. Sherpa LY, Deji, Stigum H, Chongsuvivatwong V, Luobu O, Thelle DS et al. Lipid Profile and Its Association with Risk Factors for Coronary Heart Disease in the Highlanders of Lhasa, Tibet. High Altitude Med & Biol 2011; 12: 57-63
5. Taskinen M.R., Boren J. New insights into the pathophysiology of dyslipidemia in type 2 diabetes. Atherosclerosis. 2015; 239:483–95
6. Low Wang C.C., et al. Clinical Update: Cardiovascular Disease in Diabetes Mellitus: Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus – Mechanisms, Management, and Clinical Considerations. Circulation. 2016;133:2459–502
7. Ginsberg H.N., MacCallum P.R. The obesity, metabolic syndrome, and type 2 diabetes mellitus pandemic: Part I. Increased cardiovascular disease risk and the importance of atherogenic dyslipidemia in persons with the metabolic syndrome and type two diabetes mellitus. J Cardiometab Syndr. 2009; 4: 113–9
8. Piccirillo G, Di Giuseppe V, Nocco M, Lionetti M, Moise A, Naso C, Tallarico D, Marigliano V, Cacciafesta M. Influence of ageing and other cardiovascular risk factors on baroreflex sensitivity. J Am Geriatr Soc. 2001; 49: 1059–1065